The Latest: US panel endorses 3rd vaccine option from J&J
WASHINGTON — A U.S. advisory panel has endorsed the new one-dose COVID-19 vaccine from Johnson & Johnson as a third option to bolster the national effort against the coronavirus pandemic. Advisers to the Centers for Disease Control and Prevention voted overwhelmingly to recommend the vaccine for adults 18 years old and up. The ruling followed… Read More »